Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Bronchoalveolar lavage (BAL) Clinical Research Samples
Discovery Life Sciences provides the highest quality Bronchoalveolar lavage (BAL) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Bronchoalveolar lavage (BAL) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 60 of 60 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Product Details | Price | Buy | Blood Type | Additional Notes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BAL0000-AI900405293061020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.50 | 1.00 | $200.00 | 66 Y | Male | Non-Hispanic | <-70C | 10-Jun-20 | Culture | Positive | Strep. B | $200.00 | Unknown | |||||
| BAL0000-AI900405294061020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.00 | 1.00 | $200.00 | 78 Y | Male | Non-Hispanic | <-70C | 10-Jun-20 | Culture | Positive | Candida albicans | $200.00 | Unknown | |||||
| BAL0000-AI900405295060520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.50 | 1.00 | $200.00 | 61 Y | Male | Unknown | <-70C | 05-Jun-20 | Culture | Positive | Intracellular bacteria | $200.00 | Unknown | |||||
| BAL0000-AI900405296060520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 72 Y | Male | Non-Hispanic | <-70C | 05-Jun-20 | Culture | Positive | stenotrophomonas maltophilia | Staphylococcus aureus | $200.00 | Unknown | |||||
| BAL0000-AI900405297060520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.00 | 1.00 | $200.00 | 72 Y | Male | Non-Hispanic | <-70C | 05-Jun-20 | Culture | Positive | Stenotrophomonas maltophilia | $200.00 | Unknown | |||||
| BAL0000-AI900405298060520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.00 | 1.00 | $200.00 | 72 Y | Male | Non-Hispanic | <-70C | 05-Jun-20 | Culture | Positive | Stenotrophomonas maltophilia | Mold | $200.00 | Unknown | |||||
| BAL0000-AI900405299061120DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.50 | 1.00 | $200.00 | 70 Y | Male | Non-Hispanic | <-70C | 11-Jun-20 | Culture | Positive | Staph. Aureus | $200.00 | Unknown | |||||
| BAL0000-AI900408946070820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.50 | 1.00 | $200.00 | 60 Y | Male | Non-Hispanic | <-70C | 08-Jul-20 | Culture | Positive | MRSA/E.Coli | $200.00 | Unknown | |||||
| BAL0000-AM900404996060520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.50 | 1.00 | $200.00 | 45 Y | Female | Unknown | <-70C | 05-Jun-20 | Direct Smear | Quantitative Culture | 3,000 | Candida Species | Additional Results | $200.00 | Unknown | ||||
| BAL0000-AM900404998060420DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 65 Y | Female | Unknown | <-70C | 04-Jun-20 | Direct Smear | Quantitative Culture | 100,000 | Pseudomonas aeruginosa | Additional Results | $200.00 | Unknown | ||||
| BAL0000-AM900405037060220DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.50 | 1.00 | $200.00 | 37 Y | Female | Unknown | <-70C | 02-Jun-20 | Direct Smear | Quantitative Culture | Heavy Growth | Methicillin Resistant Staphylococcus aureus | Additional Results | $200.00 | Unknown | ||||
| BAL0000-AM900405038052720DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 31 Y | Female | Unknown | <-70C | 27-May-20 | Direct Smear | Quantitative Culture | 1,000 | Candida Species | Additional Results | $200.00 | Unknown | ||||
| BAL0000-AM900405039040820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 67 Y | Male | Unknown | <-70C | 08-Apr-20 | Direct Smear | Quantitative Culture | Very Rare Growth | Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AM900405041052520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.25 | 1.00 | $200.00 | 62 Y | Female | Unknown | <-70C | 25-May-20 | Direct Smear | Quantitative Culture | 10,000 | Streptococcus intermedius | $200.00 | Unknown | |||||
| BAL0000-AM900405042052720DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 68 Y | Male | Unknown | <-70C | 27-May-20 | Direct Smear | Quantitative Culture | Moderate Growth | Enterobacter Cloacae | Additional Results | $200.00 | Unknown | ||||
| BAL0000-AM900405043052620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.25 | 1.00 | $200.00 | 1 Y | Male | Unknown | <-70C | 26-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411378052320DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 61 Y | Male | Unknown | <70C | 23-May-20 | Direct Smear | Quantitative Culture | 4000 | Candida Species | $200.00 | Unknown | Yeasts (Candida) very rarely causes respiratory tract infections.. | ||||
| BAL0000-AM900411379052620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 74 Y | Female | Unknown | <70C | 26-May-20 | Direct Smear | Quantitative Culture | 10000 | Mixed Upper Respiratory Flora | $200.00 | Unknown | |||||
| BAL0000-AM900411380052420DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 73 Y | Female | Unknown | <70C | 24-May-20 | Direct Smear | Quantitative Culture | 30000 | Mixed Upper Respiratory Flora | $200.00 | Unknown | |||||
| BAL0000-AM900411381052820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 42 Y | Male | Unknown | <70C | 28-May-20 | Direct Smear | Quantitative Culture | Light Growth | Candida Species | $200.00 | Unknown | Yeasts (Candida) very rarely causes respiratory tract infections. Please interpret the presence of this organism as an infectious agent with caution. | ||||
| BAL0000-AM900411382052520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 49 Y | Male | Unknown | <70C | 25-May-20 | Direct Smear | Quantitative Culture | 5000 | Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AM900411383051420DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 31 Y | Male | Unknown | <70C | 14-May-20 | Direct Smear | Quantitative Culture | 50000 | Staphylococcus aureus | $200.00 | Unknown | 50,000 cfu/mL Haemophilus influenzae, Beta lactamase negative, 50,000 cfu/mL mixed upper respiratory flora | ||||
| BAL0000-AM900411384052920DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.00 | 1.00 | $200.00 | 1 Y | Female | Unknown | <70C | 29-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411385052720DD | Bronchoalveolar lavage (BAL) | United States | BAL | 4.00 | 1.00 | $200.00 | 62 Y | Female | Unknown | <70C | 27-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411386052520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 40 Y | Male | Unknown | <70C | 25-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411387051820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 4.00 | 1.00 | $200.00 | 27 Y | Male | Unknown | <70C | 18-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411388052820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 56 Y | Female | Unknown | <70C | 28-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411389052920DD | Bronchoalveolar lavage (BAL) | United States | BAL | 4.00 | 1.00 | $200.00 | 77 Y | Female | Unknown | <70C | 29-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411390030520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 65 Y | Male | Unknown | <70C | 05-Mar-20 | Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411391042820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 4.00 | 1.00 | $200.00 | 74 Y | Female | Unknown | <70C | 28-Apr-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411392033020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 31 Y | Female | Unknown | <70C | 30-Mar-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411393052220DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 39 Y | Male | Unknown | <70C | 22-May-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411394032520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 2.00 | 1.00 | $200.00 | 37 Y | Female | Unknown | <70C | 25-Mar-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411395040520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 59 Y | Male | Unknown | <70C | 05-Apr-20 | Direct Smear | Quantitative Culture | No Growth | $200.00 | Unknown | ||||||
| BAL0000-AM900411396052820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 67 Y | Male | Unknown | <70C | 28-May-20 | Direct Smear | Quantitative Culture | Moderate Growth | Pseudomonas aeruginosa | $200.00 | Unknown | This Gram negative organism is a multidrug resistant organism (MDRO). A person infected with a MDRO should be in appropriate precautionary isolation consistent with institutional recommendations. No carbapenemase resistance genes were detected. This sample was tested for the VIM, IMP, KPC, OXA-48, and NDM genes using an FDA approved assay. Very Rare Growth Candida species, Yeasts (Candida) very rarely causes respiratory tract infections. Please interpret the presence of this organism as an infectious agent with caution. | ||||
| BAL0000-AM900411397051520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 4.00 | 1.00 | $200.00 | 83 Y | Male | Unknown | <70C | 15-May-20 | Direct Smear | Quantitative Culture | 20000 | Citrobacter amalonaticus | $200.00 | Unknown | 10,000 cfu/mL Candida species, Yeasts (Candida) very rarely causes respiratory tract infections. Please interpret the presence of this organism as an infectious agent with caution. 70,000 cfu/mL mixed upper respiratory flora Third generation cephalosporins are potent inducers of type 1 beta lactamases and often lead to resistance in Enterobacter spp., Citrobacter spp., and Serratia spp. to all cephalosporins within 3 to 4 days of treatment with these antibiotics. | ||||
| BAL0000-AM900411398032620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 3.00 | 1.00 | $200.00 | 56 Y | Female | Unknown | <70C | 26-Mar-20 | Direct Smear | Quantitative Culture | 40000 | Staphylococcus epidermidis | $200.00 | Unknown | 4,000 cfu/mL Candida species, No further identification or susceptibilities will be performed on this isolate unless requested. Yeasts (Candida) very rarely causes respiratory tract infections. Please interpret the presence of this organism as an infectious agent with caution. | ||||
| BAL0000-AM900411399040320DD | Bronchoalveolar lavage (BAL) | United States | BAL | 4.00 | 1.00 | $200.00 | 19 Y | Female | Unknown | <70C | 03-Apr-20 | Direct Smear | Quantitative Culture | Heavy Growth | Escherichia coli | $200.00 | Unknown | This organism produces an extended spectrum beta lactamase (ESBL) and is resistant to multiple antibiotics meeting the definition of a multiply drug resistant organism (MDRO). Infection control will be notified. Infectious disease consultation should be considered for treatment advice. Light growth Normal oral flora. | ||||
| BAL0000-AU900402212060420DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 68 Y | Male | Unknown | <-70C | 04-Jun-20 | Culture | Positive | Methicillin resistant Staphylococcus aureus | $200.00 | Unknown | |||||
| BAL0000-AU900402213060820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 69 Y | Female | Unknown | <-70C | 08-Jun-20 | Culture | Positive | Pneumocystis jirovecii, Cytomegalovirus | $200.00 | Unknown | |||||
| BAL0000-AU900402214061620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.25 | 1.00 | $200.00 | 55 Y | Female | Unknown | <-70C | 16-Jun-20 | Culture | Positive | Staphylococcus lugdunensis, Methicillin resistant Staphylococcus aureus | $200.00 | Unknown | |||||
| BAL0000-AU900402215061620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 67 Y | Male | Non-Hispanic | <-70C | 16-Jun-20 | Culture | Positive | Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AU900402219061520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 62 Y | Female | Unknown | <-70C | 15-Jun-20 | Culture | Positive | Bordetella bronchiseptica | $200.00 | Unknown | |||||
| BAL0000-AU900402221061820DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 59 Y | Female | Unknown | <-70C | 18-Jun-20 | Culture | Positive | Staphylococcus aureus | $200.00 | Unknown | |||||
| BAL0000-AU900403422052220DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 82 Y | Female | Unknown | <-70C | 22-May-20 | Culture | Positive | Mucoid Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AU900403423052220DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 41 Y | Male | Unknown | <-70C | 22-May-20 | Culture | Positive | Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AU900403424052120DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 77 Y | Female | Unknown | <-70C | 21-May-20 | Culture | Positive | Escherichia coli | $200.00 | Unknown | |||||
| BAL0000-AU900403425052020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 47 Y | Male | Unknown | <-70C | 20-May-20 | Culture | Positive | Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AU900403742050620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 59 Y | Male | Unknown | <-70C | 06-May-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900403779043020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.25 | 1.00 | $200.00 | 56 Y | Male | Unknown | <-70C | 30-Apr-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900403780042920DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.25 | 1.00 | $200.00 | 60 Y | Male | Unknown | <-70C | 29-Apr-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900403785043020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 80 Y | Male | Unknown | <-70C | 30-Apr-20 | Culture | Positive | Aspergillus species | $200.00 | Unknown | |||||
| BAL0000-AU900403796043020DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 58 Y | Female | Unknown | <-70C | 30-Apr-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900403800050620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 75 Y | Female | Non-Hispanic | <-70C | 06-May-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900403812050420DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 43 Y | Female | Unknown | <-70C | 04-May-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900403940050620DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 54 Y | Female | Unknown | <-70C | 06-May-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900405142042920DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 63 Y | Female | Unknown | <-70C | 29-Apr-20 | Culture | No organisms seen | $200.00 | Unknown | ||||||
| BAL0000-AU900406014062420DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 39 Y | Female | Unknown | <-70C | 24-Jun-20 | Culture | Positive | Stenotrophomonas maltophilia | $200.00 | Unknown | |||||
| BAL0000-AU900406214062520DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.60 | 1.00 | $200.00 | 69 Y | Male | Unknown | <-70C | 25-Jun-20 | Culture | Positive | Aspergillus fumigatus, Aspergillus terreus, Pseudomonas aeruginosa | $200.00 | Unknown | |||||
| BAL0000-AU900406260070220DD | Bronchoalveolar lavage (BAL) | United States | BAL | 1.50 | 1.00 | $200.00 | 59 Y | Male | Unknown | <-70C | 02-Jul-20 | Culture | Positive | Corynebacterium striatum | $200.00 | Unknown |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.